These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 31342946)
1. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis. Zhang Z; Yan S; Cui H; Chen H; Liu J Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946 [TBL] [Abstract][Full Text] [Related]
2. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis. Liu F; Lu X; Zhou X; Huang H Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707 [TBL] [Abstract][Full Text] [Related]
3. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis. Chen B; Ying X; Bao L Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448 [TBL] [Abstract][Full Text] [Related]
4. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer]. Wei H; Fang N; Guo L; Wu Z; Zhou Q Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870 [TBL] [Abstract][Full Text] [Related]
5. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis. Cui C; Sun X; Zhang J; Han D; Gu J J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270 [TBL] [Abstract][Full Text] [Related]
6. P16 Tuo L; Sha S; Huayu Z; Du K Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Role of RASSF1A and p16INK4a Promoter Gene Hypermethylation in Serum DNA of Lung Cancer Patients: Clinicopathological Significance. El-Sherif WT; Sayed SK; Galal SH; Makhlouf HA; Hassan AT; Yousef HA Egypt J Immunol; 2016 Jun; 23(2):1-16. PubMed ID: 28502129 [TBL] [Abstract][Full Text] [Related]
8. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
9. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the accuracy for RASSF1A methylation in bronchial aspirates for the diagnosis of lung cancer. Chen XP; He SX; Chen MY; Chen FB; Wu P; Shi P; Zhao SC; Zhao LY; Xiong XM; Zeng J PLoS One; 2024; 19(7):e0299447. PubMed ID: 39052646 [TBL] [Abstract][Full Text] [Related]
11. Ventana immunohistochemistry assay for anaplastic lymphoma kinase gene rearrangement detection in patients with non-small cell lung cancer: A meta-analysis. Zhiwei W; Yuan J; Yihui Y; Xin H; Jingtao C; Lei S; Yongjian D Thorac Cancer; 2017 Sep; 8(5):471-476. PubMed ID: 28742247 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis. Wang J; Wang B; Chen X; Bi J Carcinogenesis; 2011 Mar; 32(3):411-6. PubMed ID: 21156971 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer. Yan R; Chi L; Zheng X; Sun R; You J; Ye X Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer]. Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of methylation status of RASSF1A gene as an independent factor of non-small cell lung cancer]. Zhang H; Zhang S; Zhang Z; Jia H; Gu S; Zhao D Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):311-6. PubMed ID: 20677556 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer. Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients. Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163 [TBL] [Abstract][Full Text] [Related]
19. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis. Huang YZ; Wu W; Wu K; Xu XN; Tang WR Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469 [TBL] [Abstract][Full Text] [Related]
20. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]